Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical and Hemodynamic Correlates of Different Polarities of HD-tDCS in COPD

NCT: NCT07831629 · COMPLETED

NCT IDNCT07831629
StatusCOMPLETED
Start Date2023-10-05
Completion2024-04-30
SponsorFederal University of Paraíba (OTHER)
First posted
Last updated

Brief Summary

The aim of this pilot randomized clinical trial is to identify the acute effects of HD-tDCS in the diaphragm cortex on cerebral hemodynamics in individuals with COPD. The main questions to answer are: Is there a change in cortical metabolism (HbO and OXYHb consumption) during and immediately after the application of HD-tDCS? Are there any particularities in cortical hemodynamics between the different HD-tDCS polarities? Participants will perform three HD-tDCS sessions, each one with a different type of stimulation (anodal, cathodal and sham) lasting for 20 minutes. Before, during and after stimulation, near-infrared spectrography will be used as assessment instruments.

Frequently Asked Questions

What is Clinical and Hemodynamic Correlates of Different Polarities of HD-tDCS in COPD?

Clinical and Hemodynamic Correlates of Different Polarities of HD-tDCS in COPD is a clinical trial registered under NCT07831629. Current status: COMPLETED.

What is the status of NCT07831629?

The current status of NCT07831629 (Clinical and Hemodynamic Correlates of Different Polarities of HD-tDCS in COPD) is: COMPLETED.

When did Clinical and Hemodynamic Correlates of Different Polarities of HD-tDCS in COPD start?

Clinical and Hemodynamic Correlates of Different Polarities of HD-tDCS in COPD started on 2023-10-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.